ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Fortress Biotech Inc

Fortress Biotech Inc (FBIO)

1.87
-0.11
(-5.56%)
Closed May 22 4:00PM
1.87
0.00
( 0.00% )
Pre Market: 4:00AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
1.87
Bid
1.84
Ask
2.05
Volume
-
0.00 Day's Range 0.00
1.24 52 Week Range 10.65
Market Cap
Previous Close
1.87
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
235,485
Shares Outstanding
18,376,750
Dividend Yield
-
PE Ratio
-0.50
Earnings Per Share (EPS)
-3.74
Revenue
84.51M
Net Profit
-68.67M

About Fortress Biotech Inc

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the g... Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Dover, Delaware, USA
Founded
1970
Fortress Biotech Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker FBIO. The last closing price for Fortress Biotech was $1.87. Over the last year, Fortress Biotech shares have traded in a share price range of $ 1.24 to $ 10.65.

Fortress Biotech currently has 18,376,750 shares outstanding. The market capitalization of Fortress Biotech is $34.36 million. Fortress Biotech has a price to earnings ratio (PE ratio) of -0.50.

FBIO Latest News

Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)

MIAMI, May 16, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization...

Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

MIAMI, May 16, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term...

Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

Fortress‘ late-stage pipeline continues to advance and may generate up to three regulatory approvals on NDAs and BLAs in the next 12 months and potentially a fourth BLA filing as early as 2025...

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

SCOTTSDALE, Ariz., May 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily...

Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

– Raised a total of $9.4 million in gross proceeds from warrant exercise transactions since January 2024 – MIAMI, May 15, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI...

Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation

Helocyte, a majority-owned subsidiary of Fortress Biotech, is developing Triplex for the prevention and treatment of cytomegalovirus in multiple transplant indications, as well as HIV Clinical...

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

New Drug Application for DFD-29 to treat rosacea accepted for U.S. FDA review; PDUFA goal date of November 4, 2024 Total revenues for the first quarter ended March 31, 2024 were $13.0 million, a...

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

SCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that focuses on the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.126.857142857141.752.06971.682318561.91434906CS
40.126.857142857141.752.06971.651548591.79993309CS
12-0.35-15.76576576582.222.6151.632354851.92439251CS
26-0.34-15.38461538462.214.431.634154922.31309412CS
52-5.93-76.02564102567.810.651.245082794.49447257CS
156-55.28-96.727909011457.1567.351.2451732719.05210723CS
260-26.63-93.438596491228.591.51.2464807935.56397812CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ASTIAscent Solar Technologies Inc
$ 0.2864
(117.96%)
10.96M
ISPCiSpecimen Inc
$ 0.5201
(63.81%)
5.1M
GWAVGreenwave Technology Solutions Inc
$ 0.1118
(41.88%)
40.16M
STSSSharps Technology Inc
$ 0.3199
(26.34%)
1.41M
SUGPSU Group Holdings Ltd
$ 2.96
(16.48%)
350
MGOLMGO Global Inc
$ 0.78
(-32.76%)
307.37k
AKTSAkoustis Technologies Inc
$ 0.2152
(-31.70%)
2.74M
RDZNRoadzen Inc
$ 3.18
(-19.08%)
2.42k
BDRXBiodexa Pharmaceuticals PLC
$ 1.05
(-17.97%)
18.27k
DMTKDermTech Inc
$ 0.348
(-17.14%)
2.59k
GWAVGreenwave Technology Solutions Inc
$ 0.1118
(41.88%)
40.16M
ASTIAscent Solar Technologies Inc
$ 0.2864
(117.96%)
10.96M
BRSHBruush Oral Care Inc
$ 0.1669
(12.92%)
7.27M
ISPCiSpecimen Inc
$ 0.5201
(63.81%)
5.1M
AKTSAkoustis Technologies Inc
$ 0.2152
(-31.70%)
2.74M

FBIO Discussion

View Posts
Monksdream Monksdream 3 weeks ago
FBIO under $2
👍️0
Monksdream Monksdream 2 months ago
FBIO under $2
👍️0
triannual triannual 4 months ago
Buy order @ $1.40 / 1000 shares. GLTA!
👍️0
rbl100 rbl100 4 months ago
Not exactly certain, but I am holding for the results. I almost sold some shares for some pocket money but held off. Don't want to miss any news. My luck is I sell and then news hits and it takes off. My CA is $1.29 per share. No skin off my back with the drop.
👍️0
conix conix 5 months ago
At some point, these biotechs need to prove they have promising drug candidates in clinical trials and are not just good at raising capital
👍️ 1
Sierra20 Sierra20 5 months ago
$11 million offering. Ouch.
👍️0
Sierra20 Sierra20 5 months ago
1/3 PDUFA is no longer valid.
👍️0
rabbit67 rabbit67 5 months ago
When is next fda news jan19?
👍️0
1hot toddy 1hot toddy 5 months ago
yahoo finance says $41 price in 1 year $$$$$$$$$$$
👍️0
rbl100 rbl100 6 months ago
This thing could be like Bill Bixby. You know the 1978 series whereby just before he gets extreme stress and anger. Holding for next year+++.
👍️0
rbl100 rbl100 6 months ago
Check it out now. Glad I held. Very low float. Nice gem I was tipped off about and looking forward to the FDA approvals.
👍️0
1hot toddy 1hot toddy 6 months ago
MONSTER BIG BUYS 15000 AND 14000 SHARES. $30K EACH BUY
👍️0
rbl100 rbl100 6 months ago
Shorts kept it in check. Profit takers made it drop. No volume for them to brag about. So the drop is normal business as usual. If you see a large drop AND very large abnormal volume... that is when to worry. Remember insiders bought this stock at an average of $9.00 + per share pre R/S. They know it is going into the $40's next year... Nice 20 bagger.
👍️ 1
TrendTrade2016 TrendTrade2016 6 months ago
FBIO PUSHING UP IN PRE, LETS SEE THAT 3 DOLLA
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
Stick to your hobby of posting 52 week high and 52 week lows chief.
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
FBIO HOLY FUC!!!
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
FBIO FAB!!!
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
FBIO MONSTER
👍️0
rbl100 rbl100 6 months ago
More than the float traded today. Unless I am seeing things LOL.
👍️ 1
TrendTrade2016 TrendTrade2016 6 months ago
Chief keep posting your 52 week highs and lows. Get a better hobby
👍️0
rbl100 rbl100 6 months ago
Then don't waste your time here. No one needs anyone to protect them from themselves. We have enough with gubberment. Speaking of which should be abolished.
👍️0
Monksdream Monksdream 6 months ago
It’s a wash trade event
You’re pushing the envelope
👍️0
rbl100 rbl100 6 months ago
That is fine, but this one is looking promising as time goes on. Got to be in it to win it. FDA rubber stamps approvals these days. Years ago it was a different story. They relaxed most standards, so not worried at all. late 2020 and 2021 proved it with the CLOVER schots. FDA is nothing but a paid co-conspirator to bad. So use it to your benefit.
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
FBIO...NEXT STOP 2.27
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
FBIO...MONSTER
👍️0
Monksdream Monksdream 6 months ago
Biomed stocks and med device stocks are tricky
The sectors have a combined count of close to a thousand
Not all, in fact no more than 5% will be long winners
👍️0
rbl100 rbl100 6 months ago
Yes indeed. Better than CVM where I have been stuck since 2008 or so. Still down over 80% of my initial investment of $900 or thereabouts.
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
FBIO...HERE WE GO
👍️0
Monksdream Monksdream 6 months ago
Lucky you
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
FBIO...ON THE MOVE
👍️0
rbl100 rbl100 6 months ago
Yep and I bought up shares. Way lower than company owners bought at for sure.
👍️0
Monksdream Monksdream 6 months ago
FBIO new 52 week low
👍️0
Disquisition Disquisition 7 months ago
UNBELIEVABLE DUMPING
👍️0
Monksdream Monksdream 7 months ago
FBIO new 52 week low
👍️0
Monksdream Monksdream 8 months ago
FBIO new 52 wweek low
👍️0
Monksdream Monksdream 9 months ago
FBIO new 52 week low
👍️0
Pisd Pisd 9 months ago
Are you taunting? lol ...
👍️0
Monksdream Monksdream 9 months ago
FBIO new 52 week low
👍️0
Monksdream Monksdream 9 months ago
FBIO new 52 week low
👍️0
Pisd Pisd 9 months ago
https://ih.advfn.com/stock-market/NASDAQ/fortress-biotech-FBIO/stock-news/91811180/fortress-biotech-reports-second-quarter-2023-finan
👍️0
Pisd Pisd 9 months ago
Hi my friend..adding FBIO$ today yr low..tough crowd, gl...
👍️0
The Night Stalker The Night Stalker 1 year ago
green
👍️0
The Night Stalker The Night Stalker 1 year ago
cheap
👍️0
Spicknspan Spicknspan 1 year ago
Has FBIO gotten a NASDAQ warning letter yet?




I like the company, but needs to get over $1.00
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
FBIO IS FAB!!!
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
FBIO THERE'S THE DOLLA Break
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
FBIO CONTINUES ITS CLIMB TO A DOLLA
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
FBIO what a beautiful move off that bottom
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
FBIO building its steam
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
FBIO NEXT BIO READY TO RUMBLE
👍️0

Your Recent History

Delayed Upgrade Clock